Certified by Founder Lodge
Nodus Oncology
United Kingdom - Edinburgh, Midlothian
START UP
1 Disclosed Funding Rounds $2,911,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Nodus oncology is developing first and best-in-class molecules inhibiting novel targets within the DNA damage response and replication stress response.
Supported by most recent scientific ad
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 10 ,2023 | Unknown | $2,911,000 |
KHAN Technology Transfer Fund I
Cumulus Oncology
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Avant Genomics | $3,000,000 | (May 14, 2026)
Vector 👻 | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Data Mission | $1,000,000 | (May 14, 2026)
Dolfin | $2,460,580 | (May 14, 2026)
